<DOC>
	<DOC>NCT01584947</DOC>
	<brief_summary>The aim of the project is to do a fase two trial, where the effect of a local anesthetic lozenge will be tested in regard to oral pain, dryness of the mouth, irregularity of taste as well as investigate a potential antiinflammatory effect in patients with burning mouth syndrome, Sjögrens syndrome and lichen planus.</brief_summary>
	<brief_title>Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Anesthetics, Local</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Diagnosed with burning mouth syndrome, Sjögrens syndrome or lichen planus All fertile women need to use save contraception Age between 18 and 75 years Able to speak, read and understand the danish language Must be informed orally and release a written consent and a signed authorization statement Pregnant or breastfeeding women Known allergy to bupivacaine or other local anesthetics of the amide type Active infection which requires antibiotic treatment Patients in immune suppressive treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Oral pain</keyword>
	<keyword>Local anesthetic</keyword>
	<keyword>Bupivacaine hydrochloride</keyword>
</DOC>